magnesium-pyridoxal-5'-phosphate glutamate has been researched along with Kidney Failure, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasford, J; Heintz, B; Kirsten, R; Nelson, K; Oremek, G; Sieberth, HG; Speck, U | 1 |
1 trial(s) available for magnesium-pyridoxal-5'-phosphate glutamate and Kidney Failure, Chronic
| Article | Year |
|---|---|
Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Glutamine; Humans; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Male; Middle Aged; Pyridoxal Phosphate; Triglycerides | 1988 |